NEW YORK (GenomeWeb News) – WaferGen BioSystems said in a regulatory document that revenues for its first quarter more than doubled year over year.
It separately also announced a stock sale by shareholders of up to more than 112 million shares.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genomic analysis of 200 bird species, and more.
The Australian High Court rules that isolated genetic material cannot be patented.
The startup incubator Y Combinator is launching a nonprofit research lab.
In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.